Search

Home > News & Events > Current News

Current News

Current SATVI news

21 January 2020: Latest Research: Headway made towards biosignatures for tuberculosis incipient
Tue, 21 Jan 2020 - 15:00

Professor Tom Scriba and Dr Simon Mendelsohn have published a journal article titled: "Making headway towards biosgnatures for incipient tuberculosis" appearing in the Lancet Respiratory Medicine. 

2 December 2019: EDCTP funded clinical trial testing new tuberculosis vaccine initiates vaccinations
Wed, 18 Dec 2019 - 08:45

The Prevention of Recurrence (POR) Consortium has been awarded a substantial grant from the European & Developing Countries Clinical Trial Partnership (EDCTP) which will support a clinical trial in South Africa and Tanzania of a new and promising tuberculosis (TB) vaccine candidate H56:IC31, developed by the Statens Serum Institute (SSI). 

22 November 2019 Research Preferred product characteristics for therapeutive vaccines
Fri, 22 Nov 2019 - 13:45

Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.

14 November 2019 Research: Book Chapter: Diagnosing childhood tuberculosis during a vaccine trial in South Africa.
Thu, 14 Nov 2019 - 22:45

Dr Michèle Tameris, has co-authored a book chapter titled "Between representing and intervening: Diagnosing childhood tuberculosis during a vaccine trial in South Africa".

SATVI researcher Dr Luabeya awarded ‘C’ rating from the South African National Research Foundation.
Wed, 13 Nov 2019 - 15:45

Dr Angelique Luabeya has been awarded "C" rating from the National Research Foundation.

4 November 2019 SATVI Senior Research officer Elisa Nemes promoted to Associate Professor
Mon, 04 Nov 2019 - 15:30

The interim Dean of the UCT Faculty of Health Sciences has just announced that SATVI Senior Research Officer, Elisa Nemes has been promoted to Associate Professor. 

30 October 2019 Press Conference:Final results M72/AS01E candidate vaccine
Wed, 30 Oct 2019 - 19:30

TB Science Official Press Conference: Watch announcement  of final results from M72/AS01E candidate vaccine against tuberculosis (TB) online.

30 October 2019 Press Conference 30 October 2019 Press Conference: Final results M72/AS01E candidate vaccine
Wed, 30 Oct 2019 - 13:45

Press Conference: Towards a TB Vaccine, Union World Conference, 29 October 2019:  Watch press conference where the final results M72/AS01E candidate vaccine against tuberculosis (TB)  were announced at the Union Conference on Lung Health, India.

TB Science Conference, 2019: Final results from M72/AS01E candidate vaccine announced
Tue, 29 Oct 2019 - 17:00

Results from the MM72/AS01E  TB vaccine study have been presented at the Union Conference on Lung Health, India.

23 October 2019 Vacancy: Laboratory Technologist
Thu, 24 Oct 2019 - 11:45

SATVI is calling for applicants to the position of Laboratory Technologist at its Worcester field site. NOW CLOSED.

September 2019 Latest research: Plasma Type I IFN Protein Concentrations in Human Tuberculosis
Fri, 13 Sep 2019 - 23:00

SATVI researchers Professors Mark Hatherill, Tom Scriba, Dr Bilek, Darboe, Mbandi, Penn-Nicholson have co-authored a research article titled "Plasma Type I IFN Protein Concentrations in Human Tuberculosis." appearing in the Frontiers in Cellular and Infection Microbiology.

September 2019 Latest Research Non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis.
Fri, 13 Sep 2019 - 22:45

Professor Mark Hatherill has co-authored a journal article titled "FDG-PET/CT as a non-invasive biomarker for assessing adequacy of treatment and predicting relapse in patients treated for pulmonary tuberculosis" appearing in the Journal of Nuclear Medicine.

Pages